MedPath

Hydroxyprogesterone Caproate

Approved
Approval ID

0919b927-c57c-40ae-88a8-39e9efe4f677

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 15, 2021

Manufacturers
FDA

Mylan Institutional LLC

DUNS: 790384502

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydroxyprogesterone Caproate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67457-886
Application NumberANDA200271
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hydroxyprogesterone Caproate
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateNovember 15, 2021
FDA Product Classification

INGREDIENTS (4)

HYDROXYPROGESTERONE CAPROATEActive
Quantity: 250 mg in 1 mL
Code: 276F2O42F5
Classification: ACTIB
CASTOR OILInactive
Code: D5340Y2I9G
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
BENZYL BENZOATEInactive
Code: N863NB338G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.